Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Lung Cancer. 2021 Feb 17;154:99–104. doi: 10.1016/j.lungcan.2021.02.015

Figure 2.

Figure 2.

Representative case. A 57 year-old African American male with heavily pre-treated stage IV lung adenocarcinoma received 12 cycles of inhaled Azacitidine treatment. (Dx: Diagnosed; PR: partial response; PD: progression of disease; LE: lower extremity; SD: stable disease)